D-0311-2025 Class III Ongoing
FDA drug recall D-0311-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Mar 4, 2025 and is designated Class III. Reason for recall: Cross Contamination The recall status is ongoing. Affected quantity: 12,876 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 16, 2025
- Initiation Date
- Mar 4, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,876 bottles
Product description
Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason for recall
Cross Contamination
Distribution pattern
Nationwide in the USA
Code information
Lot # a) HAD1458A, Exp. date 04/2025, HAD2718A, Exp. date 07/2025, b) HAD3432A, exp. date 08/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0311-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026